MariMed Inc (OTCPK:MRMD)

Q1 2026 MariMed Inc Earnings Call Transcript

May 14, 2026 / 12:00 PM GMT

Release Date Price: $0.0815 (-2.98%)

Transcript 10-Q8-K

Key Points

Positve

MariMed Inc (MRMD) reported first quarter 2026 revenue of $39.5 million and positive adjusted EBITDA of $3.6 million, indicating strong financial performance.
The company achieved positive cash flow from operations, showcasing effective operational discipline.
Wholesale revenue in Illinois grew by 25% and in Delaware by 13%, strengthening their leadership position in these markets.
Betty's Eddies maintained the number one selling edible position across multiple states, demonstrating strong brand presence.
The company is expanding its dispensary footprint, with plans to open a new Thrive location in Ohio by the end of the year.

Negative

Retail revenue declined 7% sequentially, reflecting seasonal trends and market challenges.
Gross margin declined by approximately 110 basis points year-over-year, indicating some pressure on profitability.
The company faced isolated production issues in Maryland, impacting wholesale sales in that region.
Retail sales in Illinois declined 10% year-on-year, primarily due to average order volume pressure.
The rescheduling of medical cannabis has not yet led to significant changes in M&A activity or banking relationships, limiting immediate strategic benefits.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MRMD.PK - Marimed Inc
Q1 2026 MariMed Inc Earnings Call
May 14, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. My name is Tina and I will be your conference operator today. At this time, I would like to welcome everyone to the Merrimed Incorporated First Quarter 2026 Financial Results Call. All lines have been placed on mute to prevent any background noise.

After the speaker's remarks, there will be a question-and-answer session. To ask a question, simply press *1 on your telephone keypad. To withdraw your question, press *1 again. It is now my pleasure to turn the call over to Alex Schwartz, Regional Store Director for Merrimed. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.